These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29293931)

  • 1. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review.
    Schussler E; Sobel J; Hsu J; Yu P; Meaney-Delman D; Grammer LC; Nowak-Wegrzyn A
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S65-S72. PubMed ID: 29293931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.
    Yu PA; Lin NH; Mahon BE; Sobel J; Yu Y; Mody RK; Gu W; Clements J; Kim HJ; Rao AK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S57-S64. PubMed ID: 29293928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(10):299. PubMed ID: 20300057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review.
    Griese SE; Kisselburgh HM; Bartenfeld MT; Thomas E; Rao AK; Sobel J; Dziuban EJ
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S17-S29. PubMed ID: 29293924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foodborne botulism treated with heptavalent botulism antitoxin.
    Hill SE; Iqbal R; Cadiz CL; Le J
    Ann Pharmacother; 2013 Feb; 47(2):e12. PubMed ID: 23362041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.
    Fagan RP; Neil KP; Sasich R; Luquez C; Asaad H; Maslanka S; Khalil W
    Clin Infect Dis; 2011 Nov; 53(9):e125-8. PubMed ID: 21896700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016.
    O'Horo JC; Harper EP; El Rafei A; Ali R; DeSimone DC; Sakusic A; Abu Saleh OM; Marcelin JR; Tan EM; Rao AK; Sobel J; Tosh PK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S43-S56. PubMed ID: 29293927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT
    Parrera GS; Astacio H; Tunga P; Anderson DM; Hall CL; Richardson JS
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of foodborne botulism in Alexandria, Egypt: modulating indications for administration of heptavalent botulinum antitoxin.
    Ghitani SA; Ghanem MA; Sultan EA; Atef M; Henaidy MF
    Environ Sci Pollut Res Int; 2021 Nov; 28(43):61547-61553. PubMed ID: 34184216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997-2019.
    Peñuelas M; Guerrero-Vadillo M; Valdezate S; Zamora MJ; Leon-Gomez I; Flores-Cuéllar Á; Carrasco G; Díaz-García O; Varela C
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States.
    Richardson JS; Parrera GS; Astacio H; Sahota H; Anderson DM; Hall C; Babinchak T
    Clin Infect Dis; 2020 Apr; 70(9):1950-1957. PubMed ID: 31209461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan.
    Mottate K; Yokote H; Mori S; Horita A; Miyatsu Y; Torii Y; Kozaki S; Iwaki M; Takahashi M; Ginnaga A
    Toxicon; 2016 Feb; 110():12-8. PubMed ID: 26615088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of the Japanese National Standard, Equine Botulinum Antitoxin Type A, and Factors Affecting Standardization.
    Yutani M; Senoh M; Yano H; Kenri T; Iwaki M
    Jpn J Infect Dis; 2024 Jan; 77(1):16-20. PubMed ID: 37648491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
    Anderson DM; Kumar VR; Arper DL; Kruger E; Bilir SP; Richardson JS
    PLoS One; 2019; 14(11):e0224700. PubMed ID: 31697731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
    Gonul Oner O; Gudek HC; Erturk Cetin O; Demir S
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):82-84. PubMed ID: 36728838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?
    Moneim J
    Arch Dis Child; 2018 Sep; 103(9):907-909. PubMed ID: 30007943
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
    Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
    PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt.
    Hibbs RG; Weber JT; Corwin A; Allos BM; Abd el Rehim MS; Sharkawy SE; Sarn JE; McKee KT
    Clin Infect Dis; 1996 Aug; 23(2):337-40. PubMed ID: 8842274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulism During Pregnancy and the Postpartum Period: A Systematic Review.
    Badell ML; Rimawi BH; Rao AK; Jamieson DJ; Rasmussen S; Meaney-Delman D
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S30-S37. PubMed ID: 29293925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.